Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Surgical Devices
endocross.com

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$3.45M

Last Raised

$3.45M | 13 yrs ago

About Endocross

Developer of a technology for treating vascular occlusions. The company develops a chronic total occlusions (CTO) crossing devices to enhance safety in peripheral and coronary vessels. Its solution is designed to improve clinical outcome by generating distal forces at the lesion site.

Endocross Headquarter Location

Carmel House High-Tech Park (Center)

20692,

Israel

972 4 6669090

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Endocross Patents

Endocross has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/20/2011

2/12/2013

Cardiac procedures, Cardiology, Heart diseases, Angiology, Interventional cardiology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/20/2011

00/00/0000

00/00/0000

Grant Date

2/12/2013

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Cardiac procedures, Cardiology, Heart diseases, Angiology, Interventional cardiology

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.